Serum Pro-Diabetes Inflammation Biomarkers in Patients With Apical Periodontitis.
Launched by UNIVERSITY OF TURIN, ITALY · Mar 26, 2021
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
Healthy, consenting and informed patients of both gender under 55 years of age with apical periodontitis will be enrolled as cases. Healthy, consenting and informed patients of both gender under 55 years of age without apical periodontitis will be enrolled as control subjects. The study has been designed to assess the serum level of TNF-α, IL-1β, IL-6, IL-8 by ELISA assay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 25-55 years, healthy
- Exclusion Criteria:
- • under 25 years, over 55 years, patients with systemic or oral diseases or patients who underwent other dental treatments in the previous 6 months
About University Of Turin, Italy
The University of Turin, located in Italy, is a prestigious academic institution renowned for its commitment to research and innovation in the medical field. As a clinical trial sponsor, the university leverages its extensive expertise and resources to advance scientific knowledge and improve patient outcomes. Collaborating with a network of healthcare professionals and researchers, the University of Turin conducts rigorous clinical trials that adhere to the highest ethical and regulatory standards. Its focus on translational research ensures that findings contribute to the development of effective therapies and healthcare solutions, enhancing the overall well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Turin, , Italy
Turin, , Italy
Patients applied
Trial Officials
Damiano Pasqualini, DDS Ass Pro
Principal Investigator
Endodontics, Department of Surgical Sciences - Univeristy of Turin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials